Global Stem Cells Market Research Report 2023: Implications

Dublin, April 14, 2023 (GLOBE NEWSWIRE) -- The "Global Market for Stem Cells" report has been added to ResearchAndMarkets.com's offering.

This report discusses the implications of stem cell research and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets.

The important technologies supporting stem cells are reviewed, and the nature and structure of the stem cell industry is discussed, with profiles of the leading companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of the products involved.

Stem cells are the first cells formed when an egg and a sperm join, and the resultant zygote begins to divide. They are the precursors of all the different types of cells that make up the body. They are characterized by self-renewal, which is the capacity to continue dividing to make ever-larger populations of stem cells, as well as the capacity to differentiate into any mature cell type when they receive appropriate chemical instructions.

Several broad categories of stem cells exist, including embryonic stem cells, which are derived from blastocysts; fetal stem cells, which are obtained from aborted fetuses; adult stem cells, which are found in adult tissues; cord blood stem cells, which are isolated from umbilical tissue; cancer stem cells, which give rise to a clonal populations of cells that form tumors or disperse in the body; and animal stem cells, which are derived from non-human sources.

Applications

In a developing embryo, stem cells can differentiate into all of the specialized embryonic tissues. In adult organisms, stem and progenitor cells act as a repair system for the body, replenishing specialized cells. Researchers are interested in the potential for using stem cells to treat conditions, including diabetes, cardiovascular disease and neurological disorders, by replacing defective cells and tissues; ideally, stem cells function as the raw material from which new populations of normal differentiated cells and tissues develop.

Stem cells can also be used in pharmaceutical research to improve drug target validation and toxicology screening. This is of intense interest to pharmaceutical companies, as it offers a safer alternative to the use of living organisms, including humans, for some aspects of drug testing. Stem cells are also being studied for their ability to improve both the understanding and treatment of birth disorders.

Research and Commercialization

A sizeable stem cell research product market has emerged to facilitate the research resulting from interest in stem cell applications. Large companies selling stem cell research products include Invitrogen, BD Biosciences, Thermo Fisher Scientific and Millipore.

Products offered by these companies include antibodies to stem cell antigens, bead-based stem cell separation systems, stem cell protein purification and analysis tools, tools for DNA- and RNA-based Characterization of stem cells, stem cell culture and media reagents, stem-cell-specific growth factors and cytokines, tools for stem cell gene regulation, a range of stem cell services, tools for in vivo and in vitro stem cell tracking, and stem cell lines.

The major market for stem cells will be their use in the treatment of disease, and there are already numerous companies specializing in developing stem cells directed toward specific disease targets.

This market opportunity is still largely at an early, experimental stage. The main exception is the use of stem cells taken from the patient's own bone marrow to treat conditions such as leukemia, which is a failure of normal hematopoiesis (i.e., formation of blood cells). This use of stem cells is well established.

A third market opportunity has arisen in the stem cell field based on the collection and preservation of stem cells from the umbilical cord blood after a baby is born. The cells are kept frozen in "cord blood banks" so they may be used by the donor later in life to treat appropriate diseases. This use of stem cells is not generally endorsed by the medical profession, but it has given rise to a kind of medical tourism.

Report Scope

Key Attributes:

Company Profiles

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights2.1 Definitions2.2 Applications2.3 Research and Commercialization2.4 Funding2.5 Market

Chapter 3 Overview3.1 Cells3.2 Stem Cells3.2.1 Induced Pluripotent Stem Cells

Chapter 4 Stem Cell Research4.1 History4.2 Embryonic Stem Cells4.2.1 Growth and Identification of Embryonic Stem Cells4.2.2 Stimulating Embryonic Stem Cells to Differentiate4.3 Adult Stem Cells4.3.1 Mesenchymal Stem Cells4.3.2 Hematopoietic Stem Cells4.3.3 Neural Stem Cell4.3.4 Endothelial Progenitor Cell4.3.5 Epithelial Stem Cell4.3.6 Very Small Embryonic-Like Cell4.4 Cord Blood Stem Cells4.5 Induced Pluripotent Stem Cells4.5.1 Nuclear Reprogramming4.6 Cell-Based Therapeutics4.6.1 Embryonic-Derived Stem Cells4.6.2 Adult and Progenitor-Derived Stem Cells4.6.3 Engineered Stem Cells for Transplantation4.7 Therapeutic Stem Cell Banking4.8 Stem Cell-Based Biomedical Research4.9 Stem Cell Research Centers4.10 Regulation of Stem Cell Research4.10.1 National Regulatory Measures4.11 Practicalities of Stem Cell Research and Production4.11.1 Stem Cell Production4.11.2 Stem Cell Acquisition4.11.3 Stem Cell Production Economics4.11.4 Customized Therapy4.11.5 Banks4.11.6 Novel Stem Cell Production Developments4.11.7 Isolation and Engineering4.11.8 Adult Stem Cells4.11.9 Embryonic Stem Cells4.11.10 Induced Pluripotent Stem Cells4.11.11 Bioprinting4.12 Stem Cell Banking4.13 Impact of COVID-19 on Stem Cell Therapy4.13.1 Impact of COVID-19 on iPSCs

Chapter 5 Stem Cell Applications5.1 Regenerative Medicine5.2 Current Stem Cell Therapy Applications5.2.1 Cancer

Chapter 6 Stem Cell Patents6.1 General Background on Patents6.1.1 Stem Cell Patents6.2 Policies by Country6.2.1 United States6.2.2 Canada6.2.3 European Patent Convention6.2.4 United Kingdom6.2.5 Germany6.2.6 Japan6.2.7 China6.3 Induced Pluripotent Stem Cells6.4 Recent Patent Activity6.5 Clinical Trials

Chapter 7 Stem Cell Markets7.1 Markets for Stem Cells7.2 Market Dynamics7.2.1 Market Drivers7.2.2 Market Opportunities by Therapeutic Class7.3 Global Market Estimates and Forecasts7.3.1 North America7.3.2 Europe7.3.3 Asia-Pacific7.3.4 Rest of the World

Chapter 8 Emerging Technologies in the Market8.1 Stem Cell Market in 2022 and Beyond8.1.1 Oncology Applications8.1.2 Dermatology Applications8.1.3 Genetically Modified Stem Cells8.1.4 Disease Modeling8.1.5 Sustainable Meat Sources8.1.6 Bioprinting8.1.7 Surgery8.1.8 COVID-198.2 Emerging Technologies in Stem Cell Research

For more information about this report visit https://www.researchandmarkets.com/r/92vuds

About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

See original here:

Global Stem Cells Market Research Report 2023: Implications